Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.

Congratulations Laura and Roger, and keep up the good work!

More details? Click here.

OTHER NEWS

Notícies Premis

Premis Nacionals de Recerca 2025

Els recercaires ICREA, Luis Serrano i Katherine Villa han estat guardonats en la 36a edició dels Premis Nacionals de Recerca…

Notícies

25 anys d’ICREA: un èxit compartit que projecta Catalunya al futur

La Institució Catalana de Recerca i Estudis Avançats (ICREA) ha celebrat avui divendres, 6 de febrer, el seu 25è aniversari…